• Je něco špatně v tomto záznamu ?

Flavonolignans from Silybum marianum moderate UVA-induced oxidative damage to HaCaT keratinocytes

A Svobodova, A Zdarilova, D Walterova, J Vostalova

. 2007 ; 48 (3) : 213-224.

Jazyk angličtina Země Nizozemsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10026270

BACKGROUND: UV radiation from sunlight is a very potent environmental risk factor in the pathogenesis of skin cancer. Exposure to UV light, especially the UVA part, provokes the generation of reactive oxygen species (ROS), which induce oxidative stress in exposed cells. Topical application of antioxidants is a successful strategy for protecting the skin against UV-caused oxidative damage. OBJECTIVE: In this study, silybin (SB) and 2,3-dehydrosilybin (DS) (1-50 micromol/l), flavonolignan components of Silybum marianum, were tested for their ability to moderate UVA-induced damage. METHODS: Human keratinocytes HaCaT were used as an appropriate experimental in vitro model, to monitor the effects of SB and DS on cell viability, proliferation, intracellular ATP and GSH level, ROS generation, membrane lipid peroxidation, caspase-3 activation and DNA damage. RESULTS: Application of the flavonolignans (1-50 micromol/l) led to an increase in cell viability of irradiated (20 J/cm(2)) HaCaT keratinocytes. SB and DS also suppressed intracellular ATP and GSH depletion, ROS production and peroxidation of membrane lipids. UVA-induced caspases-3 activity/activation was suppressed by treatment with SB and DS. Lower concentrations of both compounds (10 micromol/l) significantly reduced cellular DNA single strand break formation. CONCLUSION: Taken together, the results suggest that these flavonolignans suppress UVA-caused oxidative stress and may be useful in the treatment of UVA-induced skin damage.

000      
00000naa 2200000 a 4500
001      
bmc10026270
003      
CZ-PrNML
005      
20111210192307.0
008      
101018s2007 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Rajnochová Svobodová, Alena $7 xx0114838
245    10
$a Flavonolignans from Silybum marianum moderate UVA-induced oxidative damage to HaCaT keratinocytes / $c A Svobodova, A Zdarilova, D Walterova, J Vostalova
314    __
$a Department of Medical Chemistry and Biochemistry, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic. alf.svoboda@seznam.cz
520    9_
$a BACKGROUND: UV radiation from sunlight is a very potent environmental risk factor in the pathogenesis of skin cancer. Exposure to UV light, especially the UVA part, provokes the generation of reactive oxygen species (ROS), which induce oxidative stress in exposed cells. Topical application of antioxidants is a successful strategy for protecting the skin against UV-caused oxidative damage. OBJECTIVE: In this study, silybin (SB) and 2,3-dehydrosilybin (DS) (1-50 micromol/l), flavonolignan components of Silybum marianum, were tested for their ability to moderate UVA-induced damage. METHODS: Human keratinocytes HaCaT were used as an appropriate experimental in vitro model, to monitor the effects of SB and DS on cell viability, proliferation, intracellular ATP and GSH level, ROS generation, membrane lipid peroxidation, caspase-3 activation and DNA damage. RESULTS: Application of the flavonolignans (1-50 micromol/l) led to an increase in cell viability of irradiated (20 J/cm(2)) HaCaT keratinocytes. SB and DS also suppressed intracellular ATP and GSH depletion, ROS production and peroxidation of membrane lipids. UVA-induced caspases-3 activity/activation was suppressed by treatment with SB and DS. Lower concentrations of both compounds (10 micromol/l) significantly reduced cellular DNA single strand break formation. CONCLUSION: Taken together, the results suggest that these flavonolignans suppress UVA-caused oxidative stress and may be useful in the treatment of UVA-induced skin damage.
650    _2
$a antioxidancia $x farmakologie $x terapeutické užití $7 D000975
650    _2
$a antioxidancia $x terapeutické užití $7 D000975
650    _2
$a kaspasa 3 $x metabolismus $7 D053148
650    _2
$a transformované buněčné linie $7 D002461
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a poškození DNA $x účinky léků $7 D004249
650    _2
$a lidé $7 D006801
650    _2
$a keratinocyty $x účinky léků $x účinky záření $7 D015603
650    _2
$a peroxidace lipidů $x účinky léků $7 D015227
650    _2
$a ostropestřec mariánský $7 D020944
650    _2
$a oxidační stres $x účinky léků $x účinky záření $7 D018384
650    _2
$a oxidační stres $x účinky záření $7 D018384
650    _2
$a radiační poranění $x prevence a kontrola $7 D011832
650    _2
$a radioprotektivní látky $x farmakologie $x terapeutické užití $7 D011837
650    _2
$a radioprotektivní látky $x terapeutické užití $7 D011837
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a silymarin $x farmakologie $7 D012838
650    _2
$a silymarin $x terapeutické užití $7 D012838
650    _2
$a kůže $x patologie $x účinky záření $7 D012867
650    _2
$a ultrafialové záření $x škodlivé účinky $7 D014466
650    _2
$a financování organizované $7 D005381
700    1_
$a Galandáková, Adéla, $d 1979- $7 stk2008428623
700    1_
$a Walterová, Daniela, $d 1943- $7 ola2002158248
700    1_
$a Vostálová, Jitka, $d 1968- $7 xx0118192
773    0_
$w MED00006643 $t Journal of dermatological science $g Roč. 48, č. 3 (2007), s. 213-224 $x 0923-1811
910    __
$a ABA008 $b x $y 7
990    __
$a 20101020113905 $b ABA008
991    __
$a 20101205111525 $b ABA008
999    __
$a ok $b bmc $g 801375 $s 666120
BAS    __
$a 3
BMC    __
$a 2007 $b 48 $c 3 $d 213-224 $i 0923-1811 $m Journal of dermatological science $n J Dermatol Sci $x MED00006643
LZP    __
$a 2010-B/jtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...